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Based on age and simple history data of patients, the CHADS2 score pro-
vides accurate assessment of the 1 year risk of stroke in the setting of atrial
fibrillation. We sought to assess the hypothesis that the CHADS2 score may
be as useful in the setting of STEMI, in comparison with more complex vali-
dated scores.
 
Methods:
 
 We assessed CHADS2, TIMI and GRACE risk scores, in 697
consecutive patients admitted for STEMI within 24 hours after the onset of
the symptom. In-hospital, 30-days, 6-months and 1-year mortality rates
were assessed according to the CHADS score (0 to 6). Low, intermediate
and high risk patients were identified by different scores : <2, 2-3, >3 for
CHADS; <4, 4-6, >6 for TIMI; <126, 126-154, > 154 for GRACE respec-
tively.
 
Results:
 
 The cumulative in-hospital, 30-day, 6-month and 1-year mortality
rates were 5.3%, 6.3%, 7.8% and 8.8% respectively. CHADS2 score was sig-
nificantly associated with all mortality rates (p<0.0001) with ORs of 2.2
(95%CI 1.7-2.8), 2.1 (95%CI 1.6-2.7), 2 (95%CI 1.6-2.7), and 2 (95%CI 1.6-
2.6) per score point respectively. The concordance between the scores in pre-
dicting 1-year mortality was fair as shown by kappa values of 0.53 and 0.50
for CHADS2 versus the 2 other and 0.53 between GRACE and TIMI scores
(Figure).
 
Conclusions:
 
 CHADS2 score is highly correlated to early and late mor-
tality after STEMI. The risk prediction by this simple purely clinical and avail-
able at first medical contact score, is concordant with more sophisticated
scores.
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Background:
 
 Inflammation plays an important role in the initiation and
progression of atherosclerosis and in the pathogenesis of acute cardiovas-
cular (CV) events. Recent studies focused on the measurement of high sen-
sitivity C-reactive protein (hsCRP) as predictors of CV events. hsCRP has
been reported to have prognostic value immediately after ACS and to be
associated with CV risk in patients with stable and unstable angina pec-
toris.
 
Aim:
 
 to evaluate the association of hsCRP levels with recurrent cardiovas-
cular events in a large prospective study of stable post-ACS patients.
 
Methods:
 
 Patients with an ACS were enrolled in our department between
2002 and 2007. HsCRP was measured at three month after the ACS together
with a global evaluation of atherosclerosis burden and risk factors. Optimal
medical treatment, a therapeutic and dietary education program was started
during the acute phase and adjusted at 3 months.
 
Results:
 
 1202 patients with hsCRP < 15 mg/l were included and the first
795 patients were followed for an average of 22 months. 94% and 75% of the
patients received a combination of b–blocker, anti- aggregates and cholesterol-
lowering drugs respectively at 3 and 22 months. LDL-cholesterol, HbA1c,
waist circumference, systolic blood pressure, metabolic syndrome, tobacco
consumption, and atherosclerosis burden were higher in the 2
 
nd
 
 and 3
 
th
 
 tertile
of hsCRP (p<0.001), at 3 months. hsCRP was associated with recurrence of
total CV events (12,0% ) (HR 1.34, CI 1.02-1.75) but was not an independent
predictor of events after adjustment to traditional CV risk factors (HR 1.19, CI
0.91-1.56). hsCRP did not significantly improve the c-statistics of the
Framingham risk evaluation.
 
Conclusion:
 
 hs CRP is associated with cardiovascular risk factors, but is
not an independent predictor of totals events in post-ACS patients receiving
optimized secondary prevention.
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Objective:
 
 High blood glucose (HBG) on admission is a major common
metabolic disorder in patients with acute myocardial infarction (MI) and is
associated with worse prognosis. However, only few data have examined its
predictive performance over established risk score.
 
Patients and methods:
 
 From a French regional survey for acute MI, we
analyzed the relationship between HBG, as defined by admission glycemia
>11 mmol/L, and 1 year mortality in patients with acute MI. All multivariate
Cox models were adjusted for the Global Registry of Acute Coronary Events
(GRACE) risk score, which is a validated 9 variables prediction tool, and
left ventricular ejection fraction as assessed by echocardiography <3 days
after admission. The additional prognostic information of HBG was tested
by comparing the –2log likelihood of the Cox models with vs without HBG
(
 
χ
 
2
 
).
 
Results:
 
 In the study population (n=3358), both admission glycemia as a
continuous variable and HBG were univariately associated with increased
mortality (HR(95%CI: 1.06(1.05-1.07) and 2.67(2.17-3.29), respectively). The
addition of either admission glycemia as a continuous variable (HR(95%CI):
1.04(1.01-1.06) or of HBG (HR(95%CI): 1.61(1.28-2.03)) significantly
improved the risk prediction in the multivariate model (
 
χ
 
2
 
: p<0.001). How-
ever, in diabetic patients (n=756), HBG failed to independently predict mor-
tality (HR(95%CI):1.17(0.80-1.71)). In contrast, in non diabetic patients
(n=2592), HBG remained an independent predictor of death (HR(95%CI):
1.93(1.39-2.67)) and added incremental prognostic value in the model over the
GRACE risk score and LVEF (
 
χ
 
2
 
: p<0.001).
 
Conclusion:
 
 High blood glucose on admission provides incremental prog-
nostic information over established risk score and LVEF, in particular in non
diabetic patients. Admission glycemia is not an independent predictive marker
in diabetic patients.
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